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Abstract
Recently, structural and biochemical studies have detailed many of the molecular events that occur in the ribosome during inhibition of protein
synthesis by antibiotics and during nascent polypeptide synthesis. Some of these antibiotics, and regulatory nascent polypeptides mostly in the
form of peptidyl-tRNAs, inhibit either peptide bond formation or translation termination1-7. These inhibitory events can stop the movement of the
ribosome, a phenomenon termed "translational arrest". Translation arrest induced by either an antibiotic or a nascent polypeptide has been
shown to regulate the expression of genes involved in diverse cellular functions such as cell growth, antibiotic resistance, protein translocation
and cell metabolism8-13. Knowledge of how antibiotics and regulatory nascent polypeptides alter ribosome function is essential if we are to
understand the complete role of the ribosome in translation, in every organism.
Here, we describe a simple methodology that can be used to purify, exclusively, for analysis, those ribosomes translating a specific mRNA and
containing a specific peptidyl-tRNA14. This procedure is based on selective isolation of translating ribosomes bound to a biotin-labeled mRNA.
These translational complexes are separated from other ribosomes in the same mixture, using streptavidin paramagnetic beads (SMB) and a
magnetic field (MF). Biotin-labeled mRNAs are synthesized by run-off transcription assays using as templates PCR-generated DNA fragments
that contain T7 transcriptional promoters. T7 RNA polymerase incorporates biotin-16-UMP from biotin-UTP; under our conditions approximately
ten biotin-16-UMP molecules are incorporated in a 600 nt mRNA with a 25% UMP content. These biotin-labeled mRNAs are then isolated, and
used in in vitro translation assays performed with release factor 2 (RF2)-depleted cell-free extracts obtained from Escherichia coli strains
containing wild type or mutant ribosomes. Ribosomes translating the biotin-labeled mRNA sequences are stalled at the stop codon region, due to
the absence of the RF2 protein, which normally accomplishes translation termination. Stalled ribosomes containing the newly synthesized
peptidyl-tRNA are isolated and removed from the translation reactions using SMB and an MF. These beads only bind biotin-containing messages.
The isolated, translational complexes, can be used to analyze the structural and functional features of wild type or mutant ribosomal components,
or peptidyl-tRNA sequences, as well as determining ribosome interaction with antibiotics or other molecular factors 1,14-16. To examine the function
of these isolated ribosome complexes, peptidyl-transferase assays can be performed in the presence of the antibiotic puromycin1. To study
structural changes in translational complexes, well established procedures can be used, such as i) crosslinking to specific amino acids14 and/or ii)
alkylation protection assays1,14,17.
Protocol
1. Cell Free Extract Preparation.
2. Preparation of Cell Free Extracts Depleted of RF2.
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1. Two grams of a dry Escherichia coli bacterial pellet obtained from mid-log phase cultures are washed, twice, with half liter of buffer A
containing 10 mM Tris-acetate, pH 8.0, 14 mM magnesium acetate, 60 mM potassium acetate, and 50 μg/ mL
phenylmethanesulphonylfluoride (PMSF) by centrifugation at 5000 X g for 5 min at 4°C. After washing, the bacterial pellet is resuspended in
40 mL of buffer A.
2. The bacterial cells are disrupted using a French Press, applying 6000 psi pressure. This pressure corresponds to 600 units using a one-inch
piston. The disrupted suspension is collected in a clean glass tube (50 mL).
3. The disrupted suspension is treated with 1 mM dithiotreitol (DTT) and is centrifuged at 30,000 x g for 30 min. The centrifugation procedure is
repeated, using the resulting supernatant. The final supernatant is dispensed (1 mL) into microtubes. Finally, the aliquots are frozen using a
dry ice-ethanol mixture or liquid nitrogen, and are stored at -60°C or -80°C.
1. 4.5 mL of protein A sepharose 4B slurry beads are mixed with 5 mL of an anti-RF2 anti-serum using a rotating wheel at room temperature, for
one hour. The mixture is centrifuged at 2500 x g to separate the beads from the antiserum. Upon discarding the supernatant, these beads
containing the anti-RF2 antibodies (anti-RF2 beads) are later washed by resuspension in 1 mL of buffer B containing 35 mM Tris-acetate pH
7.8, 10 mM magnesium acetate, 30 mM ammonium acetate, 60 mM potassium glutamate and 5 μg/ mL of leupeptin proteinase inhibitor. The
anti-RF2 beads are then separated from buffer B by centrifugation using the same conditions indicated above. The washing procedure is
repeated twice.
2. One mL of the cell-free extract is mixed with 150 μL of anti-RF2 beads using a rotating wheel, at 4°C, for two hours. The mixture is
centrifuged at 10,000 x g to separate the cell-free extract from the beads. The supernatant is removed and treated again with another 150 μL
of anti-RF2 beads. This procedure is repeated once more with the resulting cell-free extract solution. The final cell-free extract solution is
dispensed (100 μL) into microtubes. The aliquots are frozen using a dry ice-ethanol mixture or liquid nitrogen, and are stored at -60°C or
-80°C.3. Preparation of a DNA Template.
4. Preparation of Biotin Labeled mRNA.
5. Isolation of Translating Ribosomes Containing a Peptidyl-tRNA.
6. Analysis of the Isolated Ribosomes Containing the Peptidyl-tRNA.
For peptidyl-tRNA
For ribosomal RNA
7. Representative Results:
Figure 2 presents the results of a series of analyses evaluating the quality and functionality of translating ribosomes isolated using the procedure
outlined. The observation of a unique band resolved in polyacrylamide gels indicates the presence of polypeptides bound to the biotin-labeled
mRNAs attached to the SMB (Figure 2A). The purification of ribosomal RNAs using this procedure establishes the presence of ribosomes bound
to these biotin-labeled mRNAs, as well (Figure 2B). Addition of puromycin, an antibiotic that induces the peptidyl-transferase activity of the
ribosome, results in cleavage of the nascent peptidyl-tRNAs1. This is observed as a shift in the migration pattern of the isolated polypeptide in
polyacrylamide gels (Fig 2C). Together, these data indicate that biotin-labeled mRNAs attached to the SMB contain functional ribosomes with
peptidyl-tRNAs.
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1. Prepare a 1 mL PCR-reaction by mixing 600 femtomoles of the plasmid template containing the sequences to be translated (Fig 1), with 0.4
nanomoles of each of the oligodeoxynucleotides indicated in Fig 1, 0.2 micromoles of each dNTP and 50 U of Taq-DNA polymerase in the
buffer supplied by Stratagene Co. Perform the amplification reaction under the follow conditions: 94°C for 2 min, (94°C for 30 s, 55 °C for 30
s, 72°C for 1 min; for 30 cycles) and 72°C for 12 min.
2. Purify the PCR-products by precipitating the DNA by adding 1/10 volume of 3 M sodium acetate, pH 5.2, and 2 volumes of ice-cold ethanol.
Repeat the precipitation procedure once more. Resuspend the DNA in 100 μL of diethyl-pyrocarbonate (DEPC) treated-water.
Typically, this procedure yields 100 μg of a 600 bp DNA product.
3. Verify the integrity of the PCR products by electrophoresis on agarose gels.
1. Prepare a 100 μL in vitro transcription reaction in DEPC treated water by mixing 5 μg of the PCR-generated DNA fragment with 0.5
micromoles of ATP, CTP, GTP, 0.3 micromoles of UTP, 50 nanomoles of biotin-16-UTP, and 10 μL of T7 enzyme mix in the buffer supplied by
Promega Co. Incubate the reaction mixture at 37°C for 3 hours.
To quantify the amount of mRNA obtained, the DNA template should be eliminated by adding RNase-free DNase. Incubate the reaction at
37°C for 10 min.
2. Purify the mRNA products by precipitating the RNA by adding 1/10 volume of 3 M sodium acetate, pH 5.2, and 2 volumes of cold ethanol.
Repeat the precipitation procedure once more. Resuspend the mRNA in 100 μL of DEPC treated-water.
Usually, this procedure yields between 1-2 mg of a 600 nt biotin labeled mRNA product.
3. Verify the integrity of the biotin labeled mRNA products by electrophoresis on agarose gels.
1. Prepare 500 μL of an in vitro translation reaction mixture in DEPC treated water by mixing 10-15 μg of biotin-labeled mRNA with 75
nanomoles of each of the nineteen amino acids -all except the amino acid that will be replaced by a radioactive amino acid, 50 μCi of a
radioactive amino acid (37MBq), and 20-50 μL of RF2-depleted cell-free extract, in a buffered reaction mixture containing 40 mM Tris-acetate,
pH 8.0, 10 mM magnesium acetate, 175 mM potassium acetate, 10 mM ammonium acetate, 2 mM DTT, 2 mM ATP, 0.5 mM GTP, 30 mM
phosphoenolpyruvate (PEP), 0.3 U/ mL pyruvate kinase (PK), 3.5% polyethylene glycol 8000, 1 mM spermidine, 20 μg/ mL folinic acid, and
250 μg/ mL tRNA from E. coli. Incubate the reaction mixture at 37°C for 10 minutes.
The order of addition of the reaction components is very important. The cell-free extract must be mixed first with the buffer solution containing
the amino acids and the final mixture incubated for 5 min at room temperature to allow the activation of the ribosomes. Later, the
biotin-labeled mRNAs are added. For structural analyses using chemical modification procedures, the addition of a radioactive amino acid is
not required.
2. Add to the translation reaction mixture - 3 mL of streptavidin paramagnetic beads (SMB) suspended in buffer C containing 35 mM
Tris-acetate, pH 8.0, 10 mM magnesium acetate, 175 mM potassium acetate, 10 mM ammonium acetate and 1 mM DTT. Incubate the new
suspension at room temperature for 10 min.
3. Separate the SMB from the mixture by applying a magnetic field (MF) using magnetic separation stands.
4. Resuspend the SMB in buffer C and separate the beads again using the MF. Repeat this washing procedure twice. Resuspend the beads in
500 μL of buffer C, store the suspension on ice, and perform the next procedure immediately.
1. Mix 10 μL of the SMB (suspended in buffer C) with 10 μL of a loading buffer containing 50 mM Tris-HCl, pH 6.8, 2.5% (v/v) glycerol, 4%
sodium dodecyl sulfate, 2 mM DTT and 0.2 mg/ mL bromophenol blue. Resolve the components attached to the beads by running the
samples in 10% Tris-tricine polyacrylamide gels.
2. Dry the gels using a vacuum gel-dryer.
3. Verify the integrity and purification of the peptidyl-tRNA by exposing the dried gel to an X-ray film.
4. Add 190 μL of 2 mM ethylenediaminetetraacetate (EDTA) solution prepared with DEPC-treated water, and 200 μL of phenol equilibrated with
water, to 10 μL of a bead suspension. Mix the suspension by vigorous vortexing and separate the inorganic phase from the organic phase by
centrifugation at 10,000 x g for 3 min at room temperature. Collect the top water layer in a new microtube.
5. Precipitate the RNA from the water layer by adding 1/10 volume of 3 M sodium acetate, pH 5.2, 1 μL of 20 mg/ mL of glycogen solution, and
2 volumes of ice-cold ethanol. Resuspend the RNA in 10 μL of DEPC-treated water.
6. Verify the integrity of the ribosomal RNAs by electrophoresis on agarose gels.
Usually, 50 μL of beads suspension yields 1μg of ribosomal RNA.The isolation of translating ribosomes containing specific peptidyl-tRNAs permits the study of the effects of peptidyl-tRNAs, antibiotics, and other
molecules, on ribosome function (Figure 3A), and on ribosome structure (Figure 3B). In the examples presented here the antibiotic sparsomycin
and the amino acid tryptophan (Trp) inhibit the hydrolytic cleavage of the nascent tnaC-tRNA peptidyl-tRNA induced by RF2 in the isolated
ribosomes (Figure 3A). The interaction of sparsomycin or Trp with the ribosome also induces structural changes in some nucleotides that
constitute the 23S rRNA of the translating ribosome (Fig 3B). In summary, the biological material obtained using the procedure described here are
useful in obtaining additional understanding of the structural contacts involved in inhibition of ribosome function upon its interaction with various
molecular factors.
Figure 1. Procedure used to produce and purify translating ribosomes containing peptidyl-tRNAs. DNA fragments ca. 650 bp in length, containing
the tnaC gene and its adjacent region, shown in the figure, are used as templates in preparing mRNAs containing biotin, [(bio)UMP]mRNA. These
DNA fragments are produced by PCR procedures using the oligodeoxynucleotides indicated at the top of the figure. Underlined letters mark the
location of the T7 promoter encoded in the nucleotide primer. Bold letters indicate the Shine-Dalgarno sequence that is used in the translation of
the tnaC mRNA sequences. The T7 promoter in the DNA fragment is recognized by T7 RNA polymerase which is used to transcribe (arrow) the
tnaC sequence and the non-coding sequence downstream. Transcription is terminated when RNA polymerase reaches the 3'-end of the DNA
fragment, after the rpoBC terminator sequences (rpoBC"t"). The stem-loop structure of the rpoBC terminator protects the mRNA from the 3'-5'
exoribonuclease activity present in the cell-free extracts used in the in vitro translation reactions. The isolated [(bio)UMP]mRNAs are used to
generate stalled, translating ribosomes, using in vitro translation assays. The tnaC sequence in the [(bio)UMP]mRNA is translated by a ribosome
which stalls when the last amino acid is incorporated, due to the absence of the Release Factor (RF2) from the reaction mixture. The
ribosome-[(bio)UMP]mRNA complexes are isolated from the total reaction mixture using streptavidin-magnetic-beads (SMB) which bind the
biotin-labeled nucleotides incorporated in the mRNA. The SMBs bound to the ribosome-[(bio)UMP]mRNA complexes are extracted from the total
reaction mixture by using a magnetic field (MF).
Figure 2. Structural and functional analyses of the isolated complexes. A) In vitro translation reactions were performed with [(bio)UMP]mRNAs in
which the start codon of the tnaC gene was replaced by a stop codon. The final products were isolated using streptavidin beads, as is indicated in
Fig 1. Reaction products and isolated molecules were then analyzed by electrophoresis on polyacrylamide gels. The tnaC-tRNA and tnaC peptide
bands are marked. B) Total RNA was isolated from the stalled complexes using phenol extraction procedures. Each isolated RNA was resolved
by electrophoresis in agarose gels. Ribosomal RNAs (rRNAs) are indicated. C) Isolated complexes containing tnaC-tRNAs were incubated with
(+) or without (-) 0.02 mM puromycin (Puro) at room temperature for 10 min. The tnaC peptide were labeled during translation using
[35S]-methionine (A) or [3H]-proline (B).
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tryptophan. A) Isolated complexes containing tnaC-tRNAs were incubated with (+) or without (-) sparsomycin (Spar) or tryptophan (Trp) at room
temperature for 5 min. Later, the mixtures were mixed with RF2 and incubated at 37°C for 20 min. B) Analysis of methylation changes in 23S
rRNA induced by molecules binding within the ribosome. Isolated complexes were pre-incubated with (+) or without (-) 2 mM Trp or Spar for 5 min
at 37°C. Then, an alkylation agent, dimethyl sulfate, was added and the mixtures incubated at room temperature for an additional 20 min. Total
RNA was extracted and primer extension assays were performed with a [32P]-labeled oligodeoxynucleotide complementary to the nucleotides of
23S rRNA which are spaced 100 nucleotides downstream from the modified nucleotide. The final products of the extension assays were resolved
by electrophoresis in polyacrylamide gels. The 23S rRNA nucleotides affected by the presence of Trp or Spar are indicated.
Discussion
This isolation procedure described in this report is highly reproducible. Unfortunately, the presence of short peptidyl-tRNAs produced from the
same translated sequences cannot be conveniently avoided; such peptidyl-tRNAs may correspond to 15-20 % of the total isolated material
(Figure 2C). These contaminants may increase in concentration when higher concentrations of biotin-labeled mRNA have been used or when the
cell-free extracts used are old or have been re-used several times. Therefore, it is very important to control the quality and concentration of the
components of the in vitro translation reactions. Alternatively, commercial high efficiency reconstituted cell-free extracts are available that can be
used for the same purposes (PURE system)18.
Using this method, biotin-16-UMP is randomly incorporated along the length of the target mRNA. There is a possibility that some ORFs containing
uridine tracts may have incorporated this modified nucleotide in their sequences, affecting their translation. Variable relative concentrations of
biotin-16-UTP/UTP have to be tested during synthesis of the mRNA in order to obtain the most efficient translation. Alternative methods of biotin
labeling can be used, targeting the 5'-end, the most stable end of the mRNAs. (i) Biotin can be attached to the 5'-end of the mRNA using
3'-NH2ATP (3'-amino, 3'-deoxyadenosine triphosphate) and T4 RNA ligase19. (ii) 5'-end biotin-labeled oligonucleotide can be attached to the
5'-end of the mRNA using T4 RNA ligase as well20. (iii) 3'-end biotin-labeled oligodeoxynucleotides which correspond to the complementary
sequence at the 5'-end of the mRNA could also be used to isolate the translating complexes. These biotin labeled oligodeoxynucleotides could be
attached to the SMB prior to isolation. Later the SMB attached to the biotin-labeled oligodeoxynucleotides could be mixed with the translation
reaction mixture to allow interaction with their complementary mRNA sequences. After isolation, the hybrid RNA-DNA region - and the region
hybridizing between the biotin-labeled oligodeoxynucleotide and the mRNA sequence - could be degraded using RNAse H, separating the stalled
complexes from the streptavidin beads. This alternative method may allow the complexes to be employed in future structural analyses using
higher resolution methods.
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